Saba Capital Management, L.P.
Position in SLXN — Silexion Therapeutics Corp
CIK 1510281
NEW YORK, NY
Position in SLXN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
11,937
0.0% QoQ
Ownership
0.215%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SLXN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Saba Capital Management, L.P. holds $534,576 across 7 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RNA |
Atrium Therapeutics, Inc.
|
39,640 | $533,158 | |
| 2 | OABI |
OmniAb, Inc.
|
18,000 | $1,418 | |
| 3 | OSRH |
OSR Health, Inc.
|
250,000 | $0 | |
| 4 | PBM |
Psyence Biomedical Ltd.
|
297,847 | $0 | |
| 5 | CDIO |
Cardio Diagnostics Holdings, Inc.
|
199,839 | $0 | |
| 6 | LIMN |
Liminatus Pharma, Inc.
|
233,761 | $0 | |
| 7 | CDT |
CDT Equity Inc.
|
765,000 | $0 |
No Holdings History
No holdings records found for this institution in SLXN.